Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Erik H. Middlebrooks, MD"'
Autor:
Shengzhen Tao, PhD, Xiangzhi Zhou, PhD, Erin M. Westerhold, RT, Erik H. Middlebrooks, MD, Chen Lin, PhD
Publikováno v:
NeuroImage, Vol 252, Iss , Pp 119043- (2022)
Deep brain stimulation (DBS) is an increasingly utilized treatment for multiple neurological disorders. Continued improvements in DBS outcome are, in part, related to increasing ability to directly visualize stimulation targets by MRI. However, it is
Externí odkaz:
https://doaj.org/article/573c21239b0c41bc9ed2fab0e81c25e2
Autor:
Beau B. Toskich, MD, Mohamed S. Muneer, MD, Neethu Gopal, MD, Oluwaseun O. Akinduro, MD, Lina Marenco-Hillembrand, MD, Charles Ritchie, MD, David A. Miller, MD, Erik H. Middlebrooks, MD, Rabih G. Tawk, MD
Publikováno v:
Radiology Case Reports, Vol 15, Iss 11, Pp 2278-2281 (2020)
Atypical meningioma (AM) (WHO-II) has a recurrence rate of 28% after gross total resection (GTR) with limited salvage options. Transarterial therapies may provide treatment opportunities in AM patients who exhausted standard-of-care therapy. In cases
Externí odkaz:
https://doaj.org/article/135e0fb37a2342dda3d5e6164f55e774
Publikováno v:
Radiology Case Reports, Vol 13, Iss 1, Pp 89-91 (2018)
Immune checkpoint blockade (CPB) utilizing such agents as ipilimumab, nivolumab, or pembrolizumab has revolutionized melanoma therapy and has seen continued utilization in numerous other malignancies in recent years. However, these agents come at the
Externí odkaz:
https://doaj.org/article/16cccb632a254464bfe21d712d8dd2fc